Fig. 1From: Anti-malarial medicine quality field studies and surveys: a systematic review of screening technologies used and reporting of findingsDefinitions of poor quality medicines. *As of January 2017, the WHO member state mechanism has recommended that the use of “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” should be replaced with “substandard and falsified medical products”Back to article page